Last reviewed · How we verify
On-Q Pain Pump
At a glance
| Generic name | On-Q Pain Pump |
|---|---|
| Also known as | Marcaine |
| Sponsor | Maimonides Medical Center |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Cost Effectiveness in Alveolar Bone Grafting in Patients With Cleft Lip and Palate (PHASE4)
- Post-operative Cesarean Trial of Pain Control (NA)
- CLoWI Versus PCA Morphine for Pain Control After Major Abdominal Surgery (NA)
- Intraperitoneal Infusion of Analgesic for Postoperative Pain Management (PHASE4)
- Exparel Interscalene vs Indwelling Catheter (PHASE2)
- Comparison of the Effects of Epidural Analgesia and Local Infiltrative Analgesia Methods on Pain Control (NA)
- The Impact of Fast-track Perioperative Program After Liver Resection in Hong Kong Chinese Patients (NA)
- On-Q Pump vs Epidural for Postoperative Pain Control in Children (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- On-Q Pain Pump CI brief — competitive landscape report
- On-Q Pain Pump updates RSS · CI watch RSS
- Maimonides Medical Center portfolio CI